IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,163,626 | -29.0% | 125,850 | -38.1% | 0.01% | -38.9% |
| Q1 2023 | $7,271,874 | +26.3% | 203,466 | +30.8% | 0.02% | -5.3% |
| Q2 2022 | $5,758,000 | -58.5% | 155,533 | -65.9% | 0.02% | -59.6% |
| Q4 2021 | $13,865,000 | -2.0% | 455,620 | +8.0% | 0.05% | -20.3% |
| Q3 2021 | $14,154,000 | -28.9% | 422,015 | -15.4% | 0.06% | -37.2% |
| Q2 2021 | $19,896,000 | +684.5% | 498,786 | +1012.2% | 0.09% | +571.4% |
| Q4 2020 | $2,536,000 | -83.3% | 44,848 | -82.3% | 0.01% | -86.5% |
| Q3 2019 | $15,173,000 | +432.6% | 253,265 | +344.3% | 0.10% | +700.0% |
| Q3 2018 | $2,849,000 | -78.4% | 57,000 | -78.3% | 0.01% | -68.3% |
| Q4 2017 | $13,204,000 | +27.0% | 262,500 | +28.0% | 0.04% | 0.0% |
| Q3 2017 | $10,399,000 | +1381.3% | 205,100 | +1386.2% | 0.04% | +1266.7% |
| Q2 2017 | $702,000 | -89.5% | 13,800 | -90.1% | 0.00% | -91.7% |
| Q4 2016 | $6,696,000 | -41.9% | 140,000 | -24.7% | 0.04% | -55.0% |
| Q4 2015 | $11,516,000 | – | 185,954 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |